Akanda (AKAN) Total Non-Current Liabilities (2020 - 2025)

Akanda's (AKAN) quarterly Total Non-Current Liabilities came in at $12.0 million in Q4 2025, up 229.53% year-on-year from $3.6 million in Q4 2024, and up 16813.78% quarter-over-quarter from $70869.0 in Q2 2025.

Akanda (AKAN) Total Non-Current Liabilities (2020 - 2025) Analysis & Trends

Akanda's Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $12.0 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 229.53% year-over-year to $12.0 million in Q4 2025; TTM through Dec 2025 was $12.0 million, a 229.53% increase from a year earlier, with the FY2025 full-year figure at $12.0 million, up 229.53% from the prior year.
  • Total Non-Current Liabilities grew to $12.0 million in Q4 2025 per AKAN's latest filing, from $70869.0 in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $12.0 million in Q4 2025 and bottomed at $70869.0 in Q2 2025.
  • The 5-year median for Total Non-Current Liabilities is $2.5 million (2022), against an average of $3.5 million.
  • Across the five-year window, Total Non-Current Liabilities tumbled 69.9% in 2021 and surged 229.53% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $2.0 million in 2021, then soared by 38.9% to $2.7 million in 2022, then fell by 9.16% to $2.5 million in 2023, then soared by 45.67% to $3.6 million in 2024, then jumped by 229.53% to $12.0 million in 2025.
  • Per Business Quant, the three latest AKAN Total Non-Current Liabilities figures stand at $12.0 million (Q4 2025), $70869.0 (Q2 2025), and $3.6 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Akanda 556,353.85 556,353.85 - 11.99 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 11.99 Mn
Jun 30, 2025 70,869.00
Dec 31, 2024 3.64 Mn
Dec 31, 2023 2.50 Mn
Jun 30, 2023 2.48 Mn
Dec 31, 2022 2.75 Mn
Jun 30, 2022 2.57 Mn
Dec 31, 2021 1.98 Mn
Dec 31, 2020 6.58 Mn